Teleon

Teleon is an independent medical device company based in the Netherlands, specializing in the research, development, and manufacturing of intraocular lenses (IOLs) for cataract surgery and presbyopia correction. With over 30 years of experience in the IOL industry, Teleon operates its own in-house R&D department and has recently opened a modern production facility focused on innovation and quality. The company offers a diverse range of advanced IOL products, including the ACUNEX, LENTIS, and FEMTIS brands. Their portfolio features multifocal, monofocal, extended depth of focus (EDOF), and premium lenses designed to enhance surgical outcomes and improve patient vision quality. Teleon is recognized for its multifocal IOL technology, with over 800,000 implants worldwide. They also utilize the ALLY adaptive cataract treatment system to improve surgical precision. Teleon is committed to sustainability, aiming for net zero carbon emissions by 2040 through energy-efficient practices in their manufacturing facility. The company serves markets in Europe, the Middle East, Africa, Australia, New Zealand, and Singapore, collaborating with partners to distribute its ophthalmic solutions.

• Employees 180
• Founded 2017